NCT05852132View on ClinicalTrials.gov

Clinical Study on Prognosis of Patients With Severe NPDR Undergoing Vitrectomy

NANot yet recruitingINTERVENTIONAL
Enrollment

249

Participants

Timeline

Start Date

May 5, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

October 31, 2026

Conditions
Non Proliferative Diabetic Retinopathy(NPDR)
Interventions
PROCEDURE

pars plana vitrectomy(PPV)

Vitrectomy was performed for severe non-proliferative diabetic retinopathy, but panretinal photocoagulation(PRP) was not performed

PROCEDURE

Pars plana vitrectomy(PPV) +Panretinal photocoagulation(PRP)

PPV was performed for severe non-proliferative diabetic retinopathy with PRP.

PROCEDURE

Panretinal photocoagulation(PRP)

Only PRP was used for severe non-proliferative diabetic retinopathy.

Trial Locations (1)

Unknown

Tianjin medical university eye hospital, Tianjin

All Listed Sponsors
lead

Fei Gao

OTHER

NCT05852132 - Clinical Study on Prognosis of Patients With Severe NPDR Undergoing Vitrectomy | Biotech Hunter | Biotech Hunter